Emerging role of protein modification in inflammatory bowel disease

• 作者: Gaoying WANG Jintao YUAN Ji LUO Dickson Kofi Wiredu OCANSEY Xu ZHANG Hui QIAN Wenrong XU Fei MAO
• 来源期刊: 浙江大学学报（英文版）（B辑：生物医学和生物技术）
• 年，卷（期）: 2022,（3）
• 所属期刊栏目: Reviews
• 页码范围: 173-188
• 页数: 16页
• 语种: 英文

摘要

The onset of inflammatory bowel disease (IBD) involves many factors, including environmental parameters, microor-ganisms, and the immune system. Although research on IBD continues to expand, the specific pathogenesis mechanism is still unclear. Protein modification refers to chemical modification after protein biosynthesis, also known as post-translational modifi-cation (PTM), which causes changes in the properties and functions of proteins. Since proteins can be modified in different ways, such as acetylation, methylation, and phosphorylation, the functions of proteins in different modified states will also be different. Transitions between different states of protein or changes in modification sites can regulate protein properties and functions. Such modifications like neddylation, sumoylation, glycosylation, and acetylation can activate or inhibit various signaling pathways (e.g., nuclear factor-κB (NF-κB), extracellular signal-regulated kinase (ERK), and protein kinase B (AKT)) by changing the intestinal flora, regulating immune cells, modulating the release of cytokines such as interleukin-1β(IL-1β), tumor necrosis factor-α(TNF-α), and interferon-γ(IFN-γ), and ultimately leading to the maintenance of the stability of the intes-tinal epithelial barrier. In this review, we focus on the current understanding of PTM and describe its regulatory role in the patho-genesis of IBD.